Cargando…
The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine
Germ-line mutations in several genes, such as BRCA1 and BRCA2, are known to increase the risk of breast cancer. These heritable mutations are unequally represented among populations with different ethnic background due to founder effects and thereby contribute to differences in breast cancer rates i...
Autores principales: | Gorodetska, Ielizaveta, Serga, Svitlana, Levkovich, Natalia, Lahuta, Tetiana, Ostapchenko, Ludmila, Demydov, Serhyi, Anikusko, Nikolay, Cheshuk, Valeriy, Smolanka, Ivan, Sklyar, Svitlana, Polenkov, Serhyi, Boichenko, Oleksander, Kozeretska, Iryna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605451/ https://www.ncbi.nlm.nih.gov/pubmed/26468334 http://dx.doi.org/10.1186/s13053-015-0040-3 |
Ejemplares similares
-
Haplotypic characterization of BRCA1 c.5266dupC, the
prevailing mutation in Brazilian hereditary breast/ovarian
cancer
por: Gomes, Renan, et al.
Publicado: (2020) -
BRCA1 5382insC mutation in sporadic and familial breast and ovarian carcinoma in Scotland.
por: Mullen, P., et al.
Publicado: (1997) -
Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia
por: Mahfoudh, Wijden, et al.
Publicado: (2019) -
Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia
por: Plakhins, Grigorijs, et al.
Publicado: (2011) -
BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance
por: Gorodetska, Ielizaveta, et al.
Publicado: (2019)